DK1178819T3 - Anvendelse af GSSG-reduktase til behandling og forebyggelse af AIDS - Google Patents

Anvendelse af GSSG-reduktase til behandling og forebyggelse af AIDS

Info

Publication number
DK1178819T3
DK1178819T3 DK00920596T DK00920596T DK1178819T3 DK 1178819 T3 DK1178819 T3 DK 1178819T3 DK 00920596 T DK00920596 T DK 00920596T DK 00920596 T DK00920596 T DK 00920596T DK 1178819 T3 DK1178819 T3 DK 1178819T3
Authority
DK
Denmark
Prior art keywords
aids
treatment
prevention
reductase
gssg reductase
Prior art date
Application number
DK00920596T
Other languages
Danish (da)
English (en)
Inventor
Raffaele Ansovini
Original Assignee
Raffaele Ansovini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raffaele Ansovini filed Critical Raffaele Ansovini
Application granted granted Critical
Publication of DK1178819T3 publication Critical patent/DK1178819T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01007—Glutathione-disulfide reductase (1.8.1.7), i.e. glutathione reductase (NADPH)
DK00920596T 1999-05-21 2000-03-28 Anvendelse af GSSG-reduktase til behandling og forebyggelse af AIDS DK1178819T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001122A IT1312569B1 (it) 1999-05-21 1999-05-21 Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.
PCT/EP2000/002703 WO2000071146A2 (en) 1999-05-21 2000-03-28 Glutathione reductase for therapy and prophylaxis of aids

Publications (1)

Publication Number Publication Date
DK1178819T3 true DK1178819T3 (da) 2004-02-02

Family

ID=11383014

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00920596T DK1178819T3 (da) 1999-05-21 2000-03-28 Anvendelse af GSSG-reduktase til behandling og forebyggelse af AIDS

Country Status (12)

Country Link
US (1) US7045323B2 (it)
EP (1) EP1178819B1 (it)
JP (1) JP2003519088A (it)
AT (1) ATE253936T1 (it)
AU (1) AU4111600A (it)
DE (1) DE60006519T2 (it)
DK (1) DK1178819T3 (it)
ES (1) ES2211532T3 (it)
HK (1) HK1045258B (it)
IT (1) IT1312569B1 (it)
PT (1) PT1178819E (it)
WO (1) WO2000071146A2 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312569B1 (it) 1999-05-21 2002-04-22 Raffaele Ansovini Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.
ITMI20010760A1 (it) * 2001-04-10 2002-10-10 Raffaele Ansovini Associazione di enzimi coadiuvante nella terapia con interferone
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20120244212A1 (en) * 2004-11-07 2012-09-27 Frederick Timothy Guilford Enhanced method and composition for the treatment of hiv+ tuberculosis patients with anti-retroviral drugs and liposomal encapsulation for delivery of reduced glutathione
DE602006020434D1 (de) * 2005-05-17 2011-04-14 Santen Pharmaceutical Co Ltd Ein aminderivat als wirkstoff enthaltender angiogeneseinhibitor
IT1393875B1 (it) * 2009-04-29 2012-05-11 Medestea Res & Production S P A Coniugato glutatione reduttasi-peg e suo impiego come medicamento antinfluenzale
IT1401504B1 (it) * 2010-08-02 2013-07-26 Cattarini Mastelli Composizione comprendente glutatione reduttasi e glutatione ossidato

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2928417A1 (de) * 1979-07-12 1981-01-29 Schering Ag Trijodierte basen
US5843641A (en) * 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
EP0759303B1 (en) * 1994-04-22 2002-10-16 Yamanouchi Pharmaceutical Co. Ltd. Colon-specific drug release system
IL123887A0 (en) * 1997-04-02 1998-10-30 Sankyo Co Dithiolan derivatives their use and pharmaceutical compositions containing the same
US5827886A (en) * 1997-05-07 1998-10-27 Thione International, Inc. Composition for relief of arthritis-induced symptoms
IT1312569B1 (it) 1999-05-21 2002-04-22 Raffaele Ansovini Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.

Also Published As

Publication number Publication date
ATE253936T1 (de) 2003-11-15
DE60006519D1 (de) 2003-12-18
ITMI991122A1 (it) 2000-11-21
AU4111600A (en) 2000-12-12
EP1178819B1 (en) 2003-11-12
EP1178819A2 (en) 2002-02-13
WO2000071146A3 (en) 2001-03-01
PT1178819E (pt) 2004-04-30
IT1312569B1 (it) 2002-04-22
ES2211532T3 (es) 2004-07-16
DE60006519T2 (de) 2004-06-03
JP2003519088A (ja) 2003-06-17
US20040223958A1 (en) 2004-11-11
HK1045258A1 (en) 2002-11-22
WO2000071146A2 (en) 2000-11-30
US7045323B2 (en) 2006-05-16
HK1045258B (zh) 2004-04-02

Similar Documents

Publication Publication Date Title
DK1459749T3 (da) (S,S)-reboxetin til behandling af inkontinens
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
AU2002360592A8 (en) Inhibitors of hepatitis c virus
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
EP1446121A4 (en) DI-INDOLYLMETHANE FOR THE TREATMENT OF INFECTIONS BY HUMAN PAPILLOMAVIRUS
WO2001087849A3 (en) Modulators of tnf- alpha signaling
DK1178819T3 (da) Anvendelse af GSSG-reduktase til behandling og forebyggelse af AIDS
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2003210659A1 (en) Combination therapy for treatment of hiv infection
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
AP2001002369A0 (en) Pharmaceutical complex.
UA85187C2 (en) 2-aminobenzoyl derivatives
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs
EP1370697A4 (en) PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati
ZA200108398B (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.
DK1490049T3 (da) Citalopram til behandling af forhöjet blodtryk
AU3145400A (en) Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
UA32280A (uk) Спосіб формування тонко-товстокишкового анастомозу бік у бік
WO2004056374A8 (en) Use of glycyrrhizin for the treatment of standard therapy-resistant hepatitis c patients
AU2002303133A1 (en) Peroxiredoxin drugs for treatment of hiv-1 infection and methods of use thereof
AU2002336305B2 (en) Preventive and/or therapeutic agent for viral infection
AUPR723301A0 (en) Device for treatment of viral infection
AU2002336305A1 (en) Preventive and/or therapeutic agent for viral infection